Condition: Chronic Pulmonary Aspergillosis · Sponsor: Imperial College London
To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.
This description comes directly from the study's public registry record.
Dareen Marghlani, MSc · dsm20@ic.ac.uk · dsm20@ic.ac.uk
Anand Shah, PhD · s.anand@imperial.ac.uk
Always discuss trial participation with your own doctor first.
| Ninewells Hospital & Medical School | Dundee, United Kingdom | Recruiting |
| Imperial College London | London, United Kingdom | Recruiting |
| Manchester NHS Foundation Trust | Manchester, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06885905